Kyriakos Chatzopoulos

Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma

Maria Vassilakopoulou, Margaritis Avgeris, Vamsidhar Velcheti et al. · Clinical Cancer Research · 2015 · 214 citations

Medicine, Oncology, Pathology +17

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

Vassiliki Kotoula, Kyriakos Chatzopoulos, Sotiris Lakis et al. · Oncotarget · 2015 · 66 citations · Full text

Medicine, Oncology, Pathology +16

Immunostimulatory bacterial antigen–armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy

Eleni Panagioti, Cheyne Kurokawa, Kimberly Viker et al. · Journal of Clinical Investigation · 2021 · 62 citations · Full text

Medicine, Immunology, Oncology +17

CD206‐positive myeloid cells bind galectin‐9 and promote a tumor‐supportive microenvironment

Elizabeth Ann L. Enninga, Kyriakos Chatzopoulos, John T. Butterfield et al. · The Journal of Pathology · 2018 · 61 citations

Life Sciences, Immunology, Oncology +17

Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Triantafyllia Κoletsa, Vassiliki Kotoula, Georgia-Angeliki Koliou et al. · Cancer Immunology Immunotherapy · 2020 · 29 citations · Full text

Medicine, Immunology, Oncology +17